Intelligent Bio Solutions Inc
NASDAQ:INBS
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4.1
26.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Intelligent Bio Solutions Inc
NASDAQ:INBS
|
12.6m USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
210.6B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
189.1B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
137.5B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
135.2B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
126.4B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
49.4B EUR |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
58B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
54.9B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.5B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
37B USD |
Loading...
|
Market Distribution
| Min | -4 087 900% |
| 30th Percentile | -5.1% |
| Median | 6% |
| 70th Percentile | 14.8% |
| Max | 1 032 600% |
Other Profitability Ratios
Intelligent Bio Solutions Inc
Glance View
GBS, Inc. operates as a biosensor diagnostic technology company. The company is headquartered in New York City, New York and currently employs 12 full-time employees. The company went IPO on 2020-12-23. The firm is developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. The firm's Intelligent Bio Solutions is a biosensor platform, which is engaged in developing and launching diagnostic tests urgently needed to help people living with chronic diseases. The firm's subsidiary Intelligent Fingerprinting is engaged in the advancement of portable drugs of abuse testing through the analysis of fingerprint sweat. The test is non-invasive, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The firm also offers laboratory confirmation services. The system has applications within many sectors in safety-critical industries such as construction, transport and logistics firms, drug treatment organizations, as well as the United Kingdom (UK) coroners.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Intelligent Bio Solutions Inc is -317%, which is above its 3-year median of -523.9%.
Over the last 3 years, Intelligent Bio Solutions Inc’s Operating Margin has increased from -1 856.3% to -317%. During this period, it reached a low of -1 856.3% on Sep 30, 2022 and a high of -317% on Sep 30, 2025.